Showing posts with label Treatment of SAH vasospasm. Show all posts
Showing posts with label Treatment of SAH vasospasm. Show all posts

Friday, July 19, 2013

New Form of Nimodipine to Treat SAH : Nymalize

  Nymalize, an oral solution for nimodipine , has been approved to reduce the adverse affects of vasospasm in patients with subarachnoid hemorrhage. The drug was previously available in a gel cap and had to be extracted by syringe resulting in accidental IV administrations of the drug rather than the intended installation into a nasogastric tube.
Arbor Pharm